Skip to main content
Veterinary Medicines

COLISTOP POLVO PARA ADMINISTRACION EN AGUA DE BEBIDA

Authorised
  • COLISTIN SULFATE

Product identification

Medicine name:
COLISTOP POLVO PARA ADMINISTRACION EN AGUA DE BEBIDA
Active substance:
  • COLISTIN SULFATE
Target species:
  • Pig
  • Cattle (calf)
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • COLISTIN SULFATE
    500000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Pig
      • Meat and offal
        1
        day
    • Cattle (calf)
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Super's Diana S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Super's Diana S.L.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 647 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."